Skip to content

The effect of mulberry leaf black tea on the health of people with prediabetes

The effect of mulberry leaf black tea on the health of people with prediabetes

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500096574
Enrollment
Unknown
Registered
2025-01-26
Start date
2025-02-15
Completion date
Unknown
Last updated
2025-02-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

prediabetes

Interventions

control group:Accept health and nutrition knowledge promotion and education
mulberry leaf group:Brew in the form of tea, take 0.5g of 5% mulberry leaf extract (containing 25mg of 1-deoxymycin) every day
black tea group:Brew in the form of tea, take 1g of 20% black tea extract (containing 200mg of theaflavins) per day
mulberry leaf black tea group:Brew in the form of tea, take 5% mulberry leaf extract 0.5g (containing 1-deoxy-echinopsin 25mg) + 20% black tea extract 1g (containing theaflavins 200mg) every day

Sponsors

Shanghai University of Medicine & Health Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
30 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. People with prediabetes; 2. Aged 30-75 years old, with stable weight for nearly 6 months (+/-2kg); 3. Stable medication for nearly 3 months; 4. BMI >= 24 or male waist circumference >= 90cm/ female waist circumference >= 85cm.

Exclusion criteria

Exclusion criteria: 1. Myocardial infarction or stroke in the past 6 months; 2. Liver and kidney damage and concurrent medication use; 3. Diabetes or long-term use of medications that affect blood sugar control (such as systemic glucocorticoids, steroids, thiazide diuretics); 4. Disease conditions that affect energy metabolism or glucose metabolism (Cushing's syndrome, chronic kidney disease, acromegaly, cirrhosis, inflammatory bowel disease, cardiomyopathy, chronic obstructive pulmonary disease); 5. Cancer in the past 2 years; 6. Mental illness, hearing and visual impairment, and limb disability.

Design outcomes

Primary

MeasureTime frame
blood glucose;

Secondary

MeasureTime frame
Basic information such as gender, age, lifestyle, disease and medication history;Physical examination including height, weight, waist circumference, blood pressure, body composition, etc.;Complete blood test;Fecal microbial testing;Urine metabolomics;Blood lipids, liver function, kidney function, serum oxidative inflammation and other indicators;

Countries

China

Contacts

Public ContactLixin Na

Shanghai University of Medicine & Health Sciences

nalixin2003@163.com+86 138 0458 7590

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026